Evidence map›Paper›PMID 35675971›Full record

ArticleBMJ global health2022

Implementing an emergency risk communication campaign in response to the COVID-19 pandemic in Nigeria: lessons learned.

Vivianne Ihekweazu, Ukwori Ejibe, Chijioke Kaduru, Yahya Disu, Oyeronke Oyebanji, Emeka Oguanuo, Chimezie Anueyiagu, Oreoluwa Oluwabukunola Obanor, Atinuke Akande-Alegbe, Abiodun Egwuenu and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMJ global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Planning and Implementing Social Media Communication in a Public Health Crisis: An Analytical Perspective.Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Vivianne IhekweazuNigeria Health Watch, Abuja, Nigeria vivianne@nigeriahealthwatch.com.
Ukwori EjibeTony Blair Institute for Global Change, Abuja, Nigeria.
Chijioke KaduruDepartment of Prevention, Programmes & Knowledge Management, Nigeria Centre for Disease Control, Abuja, Nigeria.ORCID 0000-0002-6861-9876
Yahya DisuDepartment of Prevention, Programmes & Knowledge Management, Nigeria Centre for Disease Control, Abuja, Nigeria.
Oyeronke OyebanjiVaccine Research and Development, Coalition for Epidemic Preparedness Innovations, Oslo, Norway.
Emeka OguanuoDepartment of Prevention, Programmes & Knowledge Management, Nigeria Centre for Disease Control, Abuja, Nigeria.
Chimezie AnueyiaguDepartment of Prevention, Programmes & Knowledge Management, Nigeria Centre for Disease Control, Abuja, Nigeria.
Oreoluwa Oluwabukunola ObanorDepartment of Prevention, Programmes & Knowledge Management, Nigeria Centre for Disease Control, Abuja, Nigeria.
Atinuke Akande-AlegbeNigeria Health Watch, Abuja, Nigeria.
Abiodun EgwuenuDepartment of Prevention, Programmes & Knowledge Management, Nigeria Centre for Disease Control, Abuja, Nigeria.
Tijesu OjumuDepartment of Prevention, Programmes & Knowledge Management, Nigeria Centre for Disease Control, Abuja, Nigeria.
Abara Erim AbaraDepartment of Prevention, Programmes & Knowledge Management, Nigeria Centre for Disease Control, Abuja, Nigeria.
Chinwe Lucia OchuDepartment of Prevention, Programmes & Knowledge Management, Nigeria Centre for Disease Control, Abuja, Nigeria.ORCID 0000-0002-0630-7332
Nigeria Centre for Disease Control · NGWorld Health Organization - Nigeria · NGCoalition for Epidemic Preparedness Innovations · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

At the onset of the COVID-19 pandemic, the WHO recommended the prioritisation of risk communication and community engagement as part of response activities in countries. This was related to the increasing spread of misinformation and its associated risks, as well as the need to promote non-pharmaceutical interventions (NPIs) in the absence of an approved vaccine for disease prevention. The Nigeria Centre for Disease Control, the national public health institute with the mandate to prevent and detect infectious disease outbreaks, constituted a multidisciplinary Emergency Operations Centre (EOC), which included NCDC staff and partners to respond to the COVID-19 outbreak. Risk communication, which also comprised crisis communication, was a pillar in the EOC. As the number of cases in Nigeria increased, the increasing spread of misinformation and poor compliance to NPIs inspired the development of the #TakeResponsibility campaign, to encourage individual and collective behavioural change and to foster a shared ownership of the COVID-19 outbreak response. Mass media, social media platforms and community engagement measures were used as part of the campaign. This contributed to the spread of messages using diverse platforms and voices, collaboration with community leaders to contextualise communication materials and empowerment of communication officers at local levels through training, for increased impact. Despite the challenges faced in implementing the campaign, lessons such as the use of data and a participatory approach in developing communications campaigns for disease outbreaks were documented. This paper describes how a unique communication campaign was developed to support the response to the COVID-19 pandemic.

Indexed as

COVID-19Social MediaCommunicationHumansNigeriaPandemicshealth education and promotionhealth systemspublic health

Identifiers

PMID35675971
PMCPMC9184990
OpenAlexW4281801638

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.